yep sounds like we're basically in agreement.
I'm going to throw in a bit of speculation though, and bear in mind that this is the result of a bit of googling and no medical expertise. So take the following with a very large grain of salt.
The last line in the ann about FDA approval has a general comment about targeting "conditions where systemic LPS is believed to play a critical role". So when you google "systemic LPS" you get a bunch of links describing connections to neuroinflammation (eg Parkinson's disease).
Way back in the non-deal roadshow from March last year, the list of clinical programs includes a timeline for autism studies.
Now this is a world away from the NASH/ASH/NAFLD area. Is this idea of LPS/ neuroinflammation being linked still current or has it been discounted? Does the autism program have any momentum?
I don't want to go pushing a "magic pill" scenario but it interests me as to whether the idea of using IMM124 in neurological situations is vaguely plausible or not. My understanding is that the gut/brain thing is a trendy topic but I have no idea what the real hard science is and whether IMM124 is relevant.
But if HC is not for speculation then what is if for, that's what I say......
- Forums
- ASX - By Stock
- IMC
- Ann: Immuron Aims to Secure FDA Approval for IMM-124E
Ann: Immuron Aims to Secure FDA Approval for IMM-124E, page-51
Featured News
Add IMC (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.06M |
Open | High | Low | Value | Volume |
8.7¢ | 8.8¢ | 8.7¢ | $10.89K | 124.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4199 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 16280 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11900 | 0.084 |
1 | 50602 | 0.083 |
1 | 40638 | 0.081 |
2 | 88888 | 0.080 |
1 | 7004 | 0.079 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 16280 | 2 |
0.090 | 4450 | 1 |
0.092 | 11000 | 1 |
0.093 | 38095 | 1 |
0.094 | 164287 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online